Evidence map›Paper›PMID 26618704›Full record

ArticlePloS one2015

Exposure to Palladium Nanoparticles Affects Serum Levels of Cytokines in Female Wistar Rats.

Ivo Iavicoli, Luca Fontana, Maddalena Corbi, Veruscka Leso, Alessandro Marinaccio, Kerstin Leopold, Roland Schindl, Alessandro Sgambato

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Cell line-basedFrontiers in medicine · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Nanoparticle Exposure and Hormetic Dose-Responses: An Update.International journal of molecular sciences · 2018
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ivo IavicoliInstitute of Public Health, Section of Occupational Medicine, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168, Rome, Italy.
Luca FontanaInstitute of Public Health, Section of Occupational Medicine, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168, Rome, Italy.
Maddalena CorbiInstitute of General Pathology, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168, Rome, Italy.
Veruscka LesoInstitute of Public Health, Section of Occupational Medicine, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168, Rome, Italy.
Alessandro MarinaccioEpidemiology Unit, Occupational Medicine Department, Research Division, Italian Workers' Compensation Authority (INAIL), Via Alessandria, 220/E, 00198, Rome, Italy.
Kerstin LeopoldInstitute of Analytical and Bioanalytical Chemistry, University of Ulm, Albert Einstein-Str. 11, 89081, Ulm, Germany.
Roland SchindlInstitute of Analytical and Bioanalytical Chemistry, University of Ulm, Albert Einstein-Str. 11, 89081, Ulm, Germany.
Alessandro SgambatoInstitute of General Pathology, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168, Rome, Italy.
Università Cattolica del Sacro Cuore · ITUniversität Ulm · DEIstituto Nazionale per l'Assicurazione Contro gli Infortuni sul Lavoro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInformation currently available on the impact of palladium on the immune system mainly derives from studies assessing the biological effects of palladium salts. However, in the last years, there has been a notable increase in occupational and environmental levels of fine and ultrafine palladium particles released from automobile catalytic converters, which may play a role in palladium sensitization. In this context, the evaluation of the possible effects exerted by palladium nanoparticles (Pd-NPs) on the immune system is essential to comprehensively assess palladium immunotoxic potential.

aimTherefore, the aim of this study was to investigate the effects of Pd-NPs on the immune system of female Wistar rats exposed to this xenobiotic for 14 days, by assessing possible quantitative changes in a number of cytokines: IL-1α, IL-2, IL-4, IL-6, IL-10, IL-12, GM-CSF, INF-γ and TNF-α.

methodsTwenty rats were randomly divided into four exposure groups and one of control. Animals were given a single tail vein injection of vehicle (control group) and different concentrations of Pd-NPs (0.012, 0.12, 1.2 and 12 μg/kg). A multiplex biometric enzyme linked immunosorbent assay was used to evaluate cytokine serum levels.

resultsThe mean serum concentrations of all cytokines decreased after the administration of 0.012 μg/kg of Pd-NPs, whereas exceeded the control levels at higher exposure doses. The highest concentration of Pd-NPs (12 μg/kg) induced a significant increase of IL-1α, IL-4, IL-6, IL-10, IL-12, GM-CSF and INF-γ compared to controls. DISCUSSION AND

conclusionsThese results demonstrated that Pd-NP exposure can affect the immune response of rats inducing a stimulatory action that becomes significant at the highest administered dose. Our findings did not show an imbalance between cytokines produced by CD4+ T helper (Th) cells 1 and 2, thus suggesting a generalized stimulation of the immune system with a simultaneous activation and polarization of the naïve T cells towards Th1 and Th2 phenotype.

Indexed as

AnimalsCD4-Positive T-LymphocytesCytokinesDose-Response Relationship, DrugFemaleGene Expression RegulationMetal NanoparticlesPalladiumRandom AllocationRatsRats, WistarT-Lymphocytes, RegulatoryXenobioticsCytokinesPalladiumXenobiotics

Identifiers

PMID26618704
PMCPMC4664404
OpenAlexW2261599708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.